Caliper Life Sciences Aids the Sanger Institute's Protein Expression Project
News Apr 05, 2006
Caliper Life Sciences, Inc. announced that the Wellcome Trust Sanger Institute has purchased the microfluidic-based LabChip® 90 Automated Electrophoresis System to quality control DNA and protein within its Atlas of Protein Expression project.
The goal of the project is to systematically study the way proteins are "expressed," or produced, in cells and tissues and to create a quality, information-rich database of protein expression profiles accessible to the worldwide research community.
The Sanger Institute uses Caliper's LabChip 90 system to generate quantitative sizing, concentration, and purity data for polymerase chain reaction (PCR) products, expressed proteins, and the antibodies used for immunohistochemistry experiments.
The ability to machine microfluidic chips that are inherently more reproducible than traditional slab gels, combined with the fact that the LabChip 90 system generates real-time electronic data suitable for inter-laboratory data sharing, makes the system a good match for the project's goals.
The system also allows researchers to process multiple experiments at the same time and generate multiple data views.
"We are consistently looking for tools that can save time and redundancy in our research process," said Michael Dyson, project leader, Wellcome Trust Sanger Institute. "For this leading-edge project, we need to deploy and integrate systems that reduce intensity of human effort and provide high quality data."
Genetic Diversity Helps Protect Against DiseaseNews
Why do populations have genetic diversity when 'Survival of the Fittest' suggests that only one gene pool should thrive? It's a question that is hard to answer experimentally. A new study looking at evolutionary change in real time in tiny fungal parasites may provide a solution.
Avacta Group plc announces successful outcome of “Gene Delivery” collaboration with FIT BiotechNews
Sustained production of Affimer drugs by muscle tissue in vivo could lead to major patient and commercial benefits.READ MORE
SCRaMbLE Speeds Up Yeast EvolutionNews
Scientists have created a new way of speeding up the genome evolution of baker’s yeast Saccharomyces cerevisiae. This is to develop a synthetic yeast strain that can be transformed on demand, making it industrial applications such as the mass production of advanced medicines to treat illnesses such as malaria and tuberculosis (TB).READ MORE